Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
IDIX
|
Ag Novartis |
BUY
Open market or private purchase
|
Indirect | 1,785,714 Added 5.11% |
$4,999,999
$2.8 p/Share
|
Apr 13
2011 |
|
IOGPQ
|
Franklin Myers
Director |
SELL
Bona fide gift
|
Direct | 12,000 Reduced 22.22% |
-
|
Apr 12
2011 |
|
APOG
|
James S Porter
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 5.41% |
$66,550
$13.31 p/Share
|
Apr 12
2011 |
|
APOG
|
James S Porter
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 5.13% |
$66,500
$13.3 p/Share
|
Apr 12
2011 |
|
APOG
|
Russell Huffer
CEO, Pres |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 27.56% |
$1,353,000
$13.53 p/Share
|
Apr 11
2011 |
|
APOG
|
James S Porter
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.88% |
$67,400
$13.48 p/Share
|
Apr 11
2011 |
|
IBCP
|
Michael M Magee Jr
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 882 Reduced 4.53% |
$3,149
$3.57 p/Share
|
Apr 08
2011 |
|
IBCP
|
Michael M Magee Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,154 Added 9.96% |
-
|
Apr 08
2011 |
|
GENZ
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,681,287 Added 3.93% |
$1,578,602,675
$76.33 p/Share
|
Apr 08
2011 |
|
SPOK
|
Christopher Heim
Director |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Apr 07
2011 |
|
SPOK
|
Daniel Robert Mayleben
COO of Amcom Software Inc |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Apr 07
2011 |
|
NP
|
Sean T Erwin
Director |
SELL
Open market or private sale
|
Direct | 9,186 Reduced 100.0% |
$211,554
$23.03 p/Share
|
Apr 07
2011 |
|
NP
|
Sean T Erwin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 9,186 Added 50.0% |
$165,164
$17.98 p/Share
|
Apr 07
2011 |
|
GENZ
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 44,891,208 Added 16.16% |
-
|
Apr 07
2011 |
|
GENZ
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,947,680 Added 2.06% |
-
|
Apr 06
2011 |
|
AYI
|
Mark A Black
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 979 Reduced 2.51% |
$59,396
$60.67 p/Share
|
Apr 06
2011 |
|
AYI
|
Richard K Reece
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 731 Reduced 0.74% |
$44,350
$60.67 p/Share
|
Apr 06
2011 |
|
AYI
|
C. Dan Smith
SVP, Treasurer and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 275 Reduced 1.45% |
$16,684
$60.67 p/Share
|
Apr 06
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 38 Added 0.01% |
$7,638
$201.0 p/Share
|
Apr 06
2011 |
|
NP
|
Sean T Erwin
Director |
SELL
Open market or private sale
|
Direct | 6,447 Reduced 100.0% |
$148,152
$22.98 p/Share
|
Apr 06
2011 |
|
NP
|
Sean T Erwin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 6,447 Added 50.0% |
$115,917
$17.98 p/Share
|
Apr 06
2011 |
|
IOGPQ
|
Franklin Myers
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 35.71% |
$405,000
$13.5 p/Share
|
Apr 06
2011 |
|
FCNCA
|
Irrevocable Trust Under Agreement Dated March 28 1990
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.07% |
$39,612
$198.06 p/Share
|
Apr 05
2011 |
|
IOGPQ
|
R Brian Hanson
President & CEO |
SELL
Open market or private sale
|
Direct | 22,500 Reduced 13.02% |
$304,875
$13.55 p/Share
|
Apr 04
2011 |
|
AMKR
|
James Mac Millan Fusaro
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 136 Reduced 0.28% |
$919
$6.76 p/Share
|
Apr 03
2011 |
|
AMKR
|
Joanne Solomon
Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 136 Reduced 0.27% |
$919
$6.76 p/Share
|
Apr 03
2011 |
|
AMKR
|
Mike Lamble
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 153 Reduced 0.29% |
$1,034
$6.76 p/Share
|
Apr 03
2011 |
|
AMKR
|
Gil C. Tily
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 170 Reduced 0.3% |
$1,149
$6.76 p/Share
|
Apr 03
2011 |
|
IBCP
|
Charles C Van Loan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,934 Added 9.73% |
$12,825
$3.26 p/Share
|
Apr 01
2011 |
|
IBCP
|
Terry L Haske
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,934 Added 34.61% |
$12,825
$3.26 p/Share
|
Apr 01
2011 |
|
IBCP
|
Charles A Palmer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,087 Added 14.27% |
$13,324
$3.26 p/Share
|
Apr 01
2011 |
|
IBCP
|
Robert L Hetzler
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,934 Added 50.0% |
$12,825
$3.26 p/Share
|
Apr 01
2011 |
|
IBCP
|
Jeffrey A Bratsburg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,934 Added 30.61% |
$12,825
$3.26 p/Share
|
Apr 01
2011 |
|
IBCP
|
James E Mccarty
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,164 Added 47.45% |
$13,575
$3.26 p/Share
|
Apr 01
2011 |
|
IBCP
|
Stephen L Gulis Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,317 Added 44.73% |
$14,073
$3.26 p/Share
|
Apr 01
2011 |
|
IBCP
|
Donna J Banks
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,934 Added 48.98% |
$12,825
$3.26 p/Share
|
Apr 01
2011 |
|
FDX
|
David J Bronczek
President/COO |
SELL
Open market or private sale
|
Direct | 21,000 Reduced 23.9% |
$1,995,000
$95.0 p/Share
|
Apr 01
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 15 Added 0.0% |
$3,010
$200.7 p/Share
|
Apr 01
2011 |
|
SPOK
|
Nicholas A Gallopo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 863 Added 7.3% |
$12,496
$14.48 p/Share
|
Apr 01
2011 |
|
SPOK
|
Brian Oreilly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 691 Added 13.71% |
$10,006
$14.48 p/Share
|
Apr 01
2011 |
|
SPOK
|
Matthew Oristano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 691 Added 13.71% |
$10,006
$14.48 p/Share
|
Apr 01
2011 |
|
SPOK
|
Samme L Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 691 Added 4.56% |
$10,006
$14.48 p/Share
|
Apr 01
2011 |
|
SPOK
|
Royce Yudkoff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 691 Added 4.27% |
$10,006
$14.48 p/Share
|
Apr 01
2011 |
|
ORCL
|
Safra Catz
Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct | 162 Added 1.39% |
$5,087
$31.4 p/Share
|
Mar 31
2011 |
|
ORCL
|
Thomas Kurian
President-Product Development |
BUY
Other acquisition or disposition
|
Direct | 756 Added 2.41% |
$23,738
$31.4 p/Share
|
Mar 31
2011 |
|
KWR
|
Jose Luiz Bregolato
VP-Managing Director -SA |
SELL
Sale (or disposition) back to the issuer
|
Direct | 5,901 Reduced 49.58% |
-
|
Mar 31
2011 |
|
FDX
|
David F Rebholz
President & CEO - FedEx Ground |
SELL
Other acquisition or disposition
|
Direct | 3,950 Reduced 7.47% |
-
|
Mar 31
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 260 Added 2.46% |
$52,520
$202.0 p/Share
|
Mar 31
2011 |
|
FDX
|
T Michael Glenn
EVP MKT DEVEL/CORP COMM |
SELL
Open market or private sale
|
Direct | 31,250 Reduced 21.26% |
$2,930,938
$93.79 p/Share
|
Mar 30
2011 |
|
FDX
|
T Michael Glenn
EVP MKT DEVEL/CORP COMM |
BUY
Exercise of conversion of derivative security
|
Direct | 31,250 Added 17.53% |
$1,265,313
$40.49 p/Share
|
Mar 30
2011 |